Wells Fargo’s InflaRx IFRX Stock Holding History

Wells Fargo’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.48K	Buy	+2,000	New	+$3.76K	﹤0.01%	6243
2025 Q2	–	Sell	-2,000	Closed	-$2.04K	–	7246
2025 Q1	$2.04K	Buy	+2,000	New	+$3.77K	﹤0.01%	6152
2019 Q2	–	Sell	-105	Closed	-$4K	–	6478
2019 Q1	$4K	Buy	+105	New	+$3.91K	﹤0.01%	5772

Other funds holding IFRX

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Wells Fargo's IFRX Position: Q2 2026 in Review

Wells Fargo opened a new position in InflaRx (IFRX) in Q2 2026: 2,000 shares worth $4.48K. The stake represents ﹤0.01% of the portfolio and ranks #6243 among its holdings. This is a return to the name: Wells Fargo previously reported a position in IFRX as recently as Q1 2025.

Wells Fargo first reported a position in IFRX in Q1 2019 and has held it in 3 quarters since. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

Wells Fargo held 2,000 shares of InflaRx worth $4.48K as of Q2 2026.
InflaRx was a new Wells Fargo position in Q2 2026.
InflaRx made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6243 holding.
Wells Fargo first reported a position in InflaRx in Q1 2019 and has held it in 3 quarters since.
62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.